PharmaVault
گنجینه اطلاعات داروسازی
The Pharmaceutical Information Vault
Excipient monograph · مونوگراف ماده جانبی
pharmavault.ir
Sodium hydroxide
سود، سدیم هیدروکسید
1Nonproprietary names
- BPSodium Hydroxide
- JPSodium Hydroxide
- Ph. Eur.Sodium Hydroxide
- USP–NFSodium Hydroxide
2Synonyms and trade names
Caustic soda; lye; natrii hydroxidum; soda lye; sodium hydrate; E524
3Chemical name and CAS Registry Number
Sodium hydroxide · [1310-73-2]
UNII 55X04QC32I · PubChem CID 14798
4Empirical formula and molecular weight
NaOH · 40.00
5Functional category
pH adjuster, buffering agent
Typical concentrations: — · Dosage forms: Liquid, Semi-solid, Sterile (parenteral/ophthalmic)
6Applications in pharmaceutical formulation
Sodium hydroxide is widely used to adjust pH and to neutralise acids in parenteral, ophthalmic, oral and topical preparations, usually as a dilute solution and in very small amounts. It is used to form water-soluble salts of acidic drugs, to prepare buffer systems with weak acids, to neutralise carbomer dispersions to form gels, and to form soaps in situ with fatty acids in creams and emulsions.
7Description
White or almost white, hard, deliquescent pellets, flakes, sticks or fused masses. It is strongly alkaline and corrosive, and absorbs water and carbon dioxide rapidly from the air.
8Typical properties
- Melting point
- 318 °C
- Solubility
- very soluble in water, with strong evolution of heat; freely soluble in ethanol
- pH
- about 12 for a 0.05% w/v solution and about 13 for a 0.5% w/v solution
- Density
- about 2.1 g/cm³
- Assay
- pharmacopoeial material contains not less than about 97% total alkali as NaOH, including a limited amount of sodium carbonate
9Stability and storage conditions
Sodium hydroxide absorbs moisture and carbon dioxide from the air, forming sodium carbonate. Store in an airtight, non-metallic container (such as polyethylene) in a cool, dry place. Solutions stored in glass slowly attack the glass.
10Incompatibilities
Reacts violently with acids, liberating heat. Attacks aluminium, zinc and tin, producing flammable hydrogen. It hydrolyses esters, amides and many drugs, and may cause degradation or precipitation of alkali-sensitive drugs and excipients.
11Method of manufacture
Produced industrially by electrolysis of sodium chloride solution (brine) in membrane, diaphragm or mercury cells, with chlorine and hydrogen as co-products; the solution is concentrated and the solid is obtained by evaporation.
12Safety
In the small amounts used to adjust pH, sodium hydroxide is neutralised in the formulation and is not toxic. The solid and concentrated solutions are highly corrosive: they cause severe burns to the skin and eyes, and ingestion causes serious injury to the gastrointestinal tract.
13Handling precautions
Handle with great care. Wear chemical-resistant gloves, eye and face protection and protective clothing. Always add the solid slowly to water with stirring (never water to the solid), as the dissolution is strongly exothermic.
14Regulatory status
GRAS listed. Accepted as a food additive in Europe (E524). Included in the FDA Inactive Ingredient Database (injections, inhalation, nasal, ophthalmic, oral, otic, rectal, topical and vaginal preparations) and in parenteral and non-parenteral medicines licensed in Europe.
15Related substances
Potassium hydroxide; ammonia solution; trolamine.
16Comments
For pH adjustment use freshly prepared or standardised dilute solutions (for example 0.1–1 M), since solutions absorb carbon dioxide and change strength. The final formulation records should state the amount of sodium hydroxide added or describe it as 'quantity sufficient to adjust pH'.